Breaching Bacterial Biofilm Barriers: Efficient Combinatorial Theranostics for Multidrug-Resistant Bacterial Biofilms with a Novel Penetration-Enhanced AIEgen Probe.
Xiaohui LiuDuoyang FanXueping FengYanjun ZhengSeraphine Valeska WegnerMeihui LiuFei ChenWenbin ZengPublished in: ACS applied materials & interfaces (2022)
The formation of microbial biofilms is acknowledged as a major virulence factor in a range of persistent local infections. Failures to remove biofilms with antibiotics foster the emergence of antibiotic-resistant bacteria and result in chronic infections. As a result, the construction of effective biofilm-inhibiting and biofilm-eradicating chemicals is urgently required. Herein, we designed a water-soluble probe APDIS for membrane-active fluorescence and broad-spectrum antimicrobial actions, particularly against methicillin-resistant Staphylococcus aureus (MRSA), which shows multidrug resistance. In vitro and in vivo experiments demonstrate its high antibacterial effects comparable to vancomycin. Furthermore, it inhibits biofilm formation by effectively killing planktonic bacteria at low inhibitory concentrations, without toxicity to mammalian cells. More importantly, this probe can efficiently penetrate through biofilm barriers and exterminate bacteria that are enclosed within biofilms and startle existing biofilms. In the mouse model of implant-related biofilm infections, this probe exhibits strong antibiofilm activity against MRSA biofilms, thus providing a novel theranostic strategy to disrupt biofilms in vivo effectively. Our results indicate that this probe has the potential to be used for the development of a combinatorial theranostic platform with synergistic enhanced effects for the treatment of multidrug-resistant bacterial infections and antibiofilm medications.
Keyphrases
- candida albicans
- biofilm formation
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- multidrug resistant
- pseudomonas aeruginosa
- living cells
- quantum dots
- mouse model
- water soluble
- acinetobacter baumannii
- photodynamic therapy
- oxidative stress
- gram negative
- escherichia coli
- cystic fibrosis
- microbial community
- drug induced
- anti inflammatory